Actinium Pharmaceuticals, Inc. (ATNM) News
Follow Actinium Pharmaceuticals, Inc. (ATNM) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Actinium Pharmaceuticals to present ATNM-400 data at EANM 2026
The company plans to present first-in-human clinical data in prostate cancer and preclinical lung cancer results today.
EQUITY | Oct 19, 2026, 11:30 AM UTC
L
ATNM - Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
ATNM - Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 04, 2026, 09:05 PM UTC
L
Actinium Pharmaceuticals updates Actimab-A IP, manufacturing and NYSE listing
Actinium Pharmaceuticals (ATNM) announces Actimab-A intellectual property and manufacturing advances and provides an update on its NYSE American listing.
MNA | Aug 14, 2026, 09:02 PM UTC